
Current Price | $166.15 | Mkt Cap | $7.3B |
---|---|---|---|
Open | $172.28 | P/E Ratio | 8.64 |
Prev. Close | $166.15 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $164.50 - $175.50 | Volume | 838,756 |
52-Wk Range | $72.99 - $306.72 | Avg. Daily Vol. | 947,124 |
The Company is engaged in the development, manufacturing and marketing of rapid diagnostic solutions at the professional point-of-care in infectious diseases and reproductive health.
Current Price | $166.15 | Mkt Cap | $7.3B |
---|---|---|---|
Open | $172.28 | P/E Ratio | 8.64 |
Prev. Close | $166.15 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $164.50 - $175.50 | Volume | 838,756 |
52-Wk Range | $72.99 - $306.72 | Avg. Daily Vol. | 947,124 |
The best Bull and Bear pitches based on recency and number of recommendations.
This is one of my STARZ.Here is the thought process on this STAR: a) Divided rate over Zerob) 3 Year Beta between -5 & +3c) 15% + Insider ownershipd) No greater than -50% Growth rate for the last 3 years (tough last couple of years so good that… More
Price has become too high,,,long way to fall. Check out 10-year chart...
Read the most recent pitches from players about QDEL.
Recs
Poised to get bigger and bigger.
Recs
QDEL is not only about COVID-19 testing but it also has rapid Troponin (Test for Myocardial Infarction or an acute Heart attack detection. Anyone visiting an ER with Chest pain complaints needs three of those tests done. Just look at their EPS of >8.5.. This company is going places
Recs
Due to COVID testing, third-quarter revenue increased 276% year over year to $461 million. Before COVID, sales had grown from $192 million in 2016 to $535 million in 2019, and its Savanna testing device -- a mid-2021 planned launch -- offers another avenue for growth in the $8.6 billion molecular diagnostics market.
Find the members with the highest scoring picks in QDEL.
robertsylvia (< 20) Score: +1,626.85
The Score Leader is the player with the highest score across all their picks in QDEL.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
WildCAPS | 80.96 | 3/17/2009 |
![]() |
3M | $7.77 | +2,038.35% | +411.50% | +1,626.85 | 0 Comment | |
robertsylvia | < 20 | 3/17/2009 |
![]() |
NS | $7.77 | +2,038.35% | +411.50% | +1,626.85 | 0 Comment | |
SSPX3 | < 20 | 4/24/2009 |
![]() |
NS | $8.50 | +1,854.71% | +349.08% | +1,505.63 | 0 Comment | |
saaf569 | 60.76 | 3/23/2009 |
![]() |
3Y | $8.59 | +1,834.23% | +390.63% | +1,443.59 | 0 Comment | |
jygalye | 49.54 |
|
![]() |
1Y | $10.36 | +1,503.76% | +182.63% | +1,321.13 | 0 Comment | |
danonwilfon | 56.24 | 3/1/2007 |
![]() |
3M | $10.65 | +1,460.09% | +191.24% | +1,268.86 | 0 Comment | |
MrProbabilistic | 24.62 | 3/9/2007 |
![]() |
NS | $10.84 | +1,432.75% | +187.17% | +1,245.58 | 1 Comment | |
acf8vj | < 20 | 3/12/2007 |
![]() |
3M | $11.04 | +1,404.98% | +188.61% | +1,216.37 | 0 Comment | |
withoutlimits | 84.49 | 4/27/2009 |
![]() |
5Y | $10.03 | +1,556.53% | +348.52% | +1,208.01 | 1 Comment | |
sandrick | 80.70 | 4/28/2009 |
![]() |
3W | $10.11 | +1,543.42% | +354.63% | +1,188.79 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.